Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Live attenuated influenza A virus vaccines with modified NS1 proteins for veterinary use

Frontiers in Cellular and Infection Microbiology(2022)10.3389/fcimb.2022.954811Source: DataRank Database

Live attenuated influenza A virus vaccines with modified NS1 proteins for veterinary use is a research paper published in Frontiers in Cellular and Infection Microbiology (2022). On theSindex it has a DataRank of 0. It has been cited 24 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access24 citations

Download PDF

Cite:

Linked data & code

nct doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 2.94)OA: goldTopics (41)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (3)

Marta L. DeDiego ORCID,Luis Martínez‐Sobrido ORCID,Aitor Nogales ORCID

Live enrichment

PubMed:35937688 PMC:PMC9354547 OpenAlex:https://openalex.org/W4286716412

NIAID NIH HHS

Grant: R01 AI145332

NIAID NIH HHS

Grant: R01 AI141607

National Institutes of Health

Grant: 5R01AI145332-03

Dynamics of the protective vaccine-induced human influenza neuraminidase B cell response

National Institutes of Health

Grant: 5R01AI141607-03

Development of a High-Throughput Microfluidics-Enabled Functional Assay for Rapidly Identifying Neutralizing Antibodies

FWCI

2.94

Citation Percentile

0.9%

Citation Trend

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://www.frontiersin.org/articles/10.3389/fcimb.2022.954811/pdf

journalhttps://doi.org/10.3389/fcimb.2022.954811

repositoryhttps://pubmed.ncbi.nlm.nih.gov/35937688

repositoryhttp://hdl.handle.net/10261/305027

repositoryhttps://doaj.org/article/31e5fbb26ba2443696c96b585c31df30

Fields of Study

Influenza Virus Research StudiesRespiratory viral infections researchAnimal Disease Management and Epidemiology0301 basic medicine0303 health sciences03 medical and health sciences

MeSH Terms

AnimalsHumansInfluenza, HumanMammalsInfluenza A virusVaccines, AttenuatedVirus ReplicationViral Nonstructural Proteins

Keywords

BiologyVirologyInfluenza A virusInnate immune systemImmune systemVirusAttenuated vaccineLive attenuated influenza vaccineImmunologyGeneGeneticsInfluenza vaccineVirulenceInterferonLive-attenuated Influenza Vaccine (Laiv)Non-structural 1 (Ns1) ProteinDifferentiating Infected From Vaccinated Animals (Diva)MammalsViral Nonstructural ProteinsVaccines, AttenuatedVirus ReplicationMicrobiologyQR1-502Cellular and Infection MicrobiologyInfluenza, HumanAnimalsHumans

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Partnerships for the goals

Live attenuated influenza A virus vaccines with modified NS1 proteins for veterinary use

FAIR Checklist

Authors (3)

Funding (4 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)